Aclaris Therapeutics (ACRS) Common Equity (2014 - 2026)
Aclaris Therapeutics (ACRS) posted Common Equity of $124.58 million for Q2 2026, down 5.4% from $131.74 million a year earlier and down 13.3% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Common Equity (2014 - 2026) Analysis & Trends
At the end of FY2025, Aclaris Therapeutics' Common Equity came in at $103.08 million, down 33.7% from FY2024.
- Annual Common Equity has declined for three consecutive years, though with a five-year compound annual growth rate of 22.3% (FY2020 to FY2025).
- In prior years, Aclaris Therapeutics' Common Equity was $155.55 million in FY2024 (-1.0%), $157.18 million in FY2023 (-20.5%), $197.62 million in FY2022 (+0.1%) and $197.34 million in FY2021 (+424.1%).
- Quarterly Common Equity has run from a low of $103.08 million in Q4 2025 to a high of $235.75 million in Q2 2022 over five years.
- On a year-over-year basis, Common Equity has declined in each of the last five quarters, with an average decline of 8.1% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q3 2021, with growth of 431.4%; the weakest was Q4 2025, with a decline of 33.7%.
- According to Business Quant data, Common Equity for the three prior quarters was $143.65 million (Q1 2026), $103.08 million (Q4 2025) and $120.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Aclaris Therapeutics | 759.25 Mn | 759.25 Mn | 1.41 Mn | 124.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 124.58 Mn |
| Mar 31, 2026 | 143.65 Mn |
| Dec 31, 2025 | 103.08 Mn |
| Sep 30, 2025 | 120.10 Mn |
| Jun 30, 2025 | 131.74 Mn |
| Mar 31, 2025 | 144.07 Mn |
| Dec 31, 2024 | 155.55 Mn |
| Sep 30, 2024 | 130.15 Mn |
| Jun 30, 2024 | 133.82 Mn |
| Mar 31, 2024 | 142.01 Mn |
| Dec 31, 2023 | 157.18 Mn |
| Sep 30, 2023 | 156.33 Mn |
| Jun 30, 2023 | 179.75 Mn |
| Mar 31, 2023 | 176.81 Mn |
| Dec 31, 2022 | 197.62 Mn |
| Sep 30, 2022 | 219.84 Mn |
| Jun 30, 2022 | 235.75 Mn |
| Mar 31, 2022 | 180.20 Mn |
| Dec 31, 2021 | 197.34 Mn |
| Sep 30, 2021 | 216.58 Mn |
API Access
Aclaris Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();